Bovine serum albumin nanoparticles for delivery of tacrolimus to reduce its kidney uptake and functional nephrotoxicity

International Journal of Pharmaceutics

Volumn 483, Issue 1-2, 2015, Pages 180-187

  Zhao, Lei ^a   Zhou, Yanxia ^a   Gao, Yajie ^a   Ma, Shujin ^a   Zhang, Chao ^a   Li, Jinwen ^a   Wang, Dishi ^a   Li, Xueping ^a   Li, Chengwei ^a   Liu, Yan ^a   Li, Xinru ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Bovine serum albumin nanoparticles; Nephrotoxicity; Pharmacokinetics; Tacrolimus; Tissue distribution

Indexed keywords

BOVINE SERUM ALBUMIN; CREATININE; NANOPARTICLE; TACROLIMUS; DRUG CARRIER;

ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; CIRCULATION TIME; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CREATININE URINE LEVEL; DISPERSION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; KIDNEY FUNCTION; KIDNEY TUBULE ABSORPTION; MALE; MEAN RESIDENCE TIME; NANOEMULSION; NANOENCAPSULATION; NEPHROTOXICITY; NONHUMAN; PHYSICAL CHEMISTRY; PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; SUSTAINED DRUG RELEASE; TISSUE DISTRIBUTION; UREA NITROGEN BLOOD LEVEL; URINE VOLUME; ZETA POTENTIAL; ANIMAL; BOVINE; CHEMISTRY; CONFORMATION; DOSE RESPONSE; DRUG EFFECTS; KIDNEY; PARTICLE SIZE; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; CATTLE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; KIDNEY; MALE; MOLECULAR CONFORMATION; NANOPARTICLES; PARTICLE SIZE; RATS; RATS, SPRAGUE-DAWLEY; SERUM ALBUMIN, BOVINE; TACROLIMUS; TISSUE DISTRIBUTION;

EID: 84923079818     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2015.02.018     Document Type: Article

References (49)

1. H.M. Aliabadi, S. Elhasi, D.R. Brocks, and A. Lavasanifar Polymeric micellar delivery reduces kidney distribution and nephrotoxic effects of cyclosporine A after multiple dosing J. Pharm. Sci. 97 2008 1916 1926
2. Y. Bottiger, C. Brattstrom, G. Tyden, J. Sawe, and C.G. Groth Tacrolimus whole blood concentrations correlate closely to side-effects in renal transplant recipients Br. J. Clin. Pharmacol. 48 1999 445 448
3. M. Breunig, S. Bauer, and A. Goepferich Polymers and nanoparticles: intelligent tools for intracellular targeting? Eur. J. Pharm. Biopharm. 68 2008 112 128
4. M.E. Brewster, and T. Loftsson Cyclodextrins as pharmaceutical solubilizers Adv. Drug Deliv. Rev. 59 2007 645 666
5. M.E. Cardenas, D. Zhu, and J. Heitman Molecular mechanisms of immunosuppression by cyclosporine FK506, and rapamycin Curr. Opin. Nephrol. Hypertens. 4 1995 472 477
6. Y.H. Chen, Y.X. Liang, L.Q. Chen, J.J. Liang, J. Zhang, J. Qiu, W.L. Li, J.B. Hu, K.J. Xie, W.D. Zhong, L.Z. Chen, and K.L. Zheng Prevention of diltiazem in tacrolimus-induced nephrotoxicity: experiment with rats Zhonghua Yi Xue Za Zhi 87 2007 2235 2237
7. Y.H. Chen, Y.X. Liang, L.Q. Chen, Y.M. Lu, J.J. Liang, J. Zhang, J. Qiu, K.J. Xie, J.B. Hu, W.D. Zhong, B. Wang, L.Z. Chen, and K.L. Zheng Nephrotoxicity of tacrolimus and preventive effect of diltiazem: experiment with rats Zhonghua Yi Xue Za Zhi 89 2009 704 708
8. J. Cortes, and C. Saura Nanoparticle albumin-bound (nab™)-paclitaxel: improving efficacy and tolerability by targeted drug delivery in metastatic breast cancer Eur. J. Cancer Suppl. 8 2010 1 10
9. X. Duan, and Y. Li Physicochemical characteristics of nanoparticles affect circulation, biodistribution, cellular internalization, and trafficking Small 9 2013 1521 1532
10. A.O. Elzoghby Gelatin-based nanoparticles as drug and gene delivery systems: reviewing three decades of research J. Control. Release 172 2013 1075 1091
11. A.O. Elzoghby, W.M. Samy, and N.A. Elgindy Albumin-based nanoparticles as potential controlled release drug delivery systems J. Control. Release 157 2012 168 182
12. E. Fattal, C. Vauthier, I. Aynie, Y. Nakada, G. Lambert, C. Malvy, and P. Couvreur Biodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotides J. Control. Release 53 1998 137 143
13. R. Fernandez-Urrusuno, P. Calvo, C. Remunan-Lopez, J.L. Vila-Jato, and M.J. Alonso Enhancement of nasal absorption of insulin using chitosan nanoparticles Pharm. Res. 16 1999 1576 1581
14. C. Freitas, and R.H. Müller Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN™) dispersions Int. J. Pharm. 168 1998 221 229
15. Q. Fu, J. Sun, W. Zhang, X. Sui, Z. Yan, and Z. He Nanoparticle albumin-bound (NAB) technology is a promising method for anti-cancer drug delivery Recent Pat. Anti-Cancer Drug Discov. 4 2009 262 272
16. S. Gao, J. Sun, D. Fu, H. Zhao, M. Lan, and F. Gao Preparation, characterization and pharmacokinetic studies of tacrolimus-dimethyl-beta-cyclodextrin inclusion complex-loaded albumin nanoparticles Int. J. Pharm. 427 2012 410 416
17. E.K. Geissler, and H.J. Schlitt Immunosuppression for liver transplantation Gut 58 2009 452 463
18. S. Harsha Pharmaceutical suspension containing both immediate/sustained-release amoxicillin-loaded gelatin nanoparticles: preparation and in vitro characterization Drug Des. Dev. Ther. 7 2013 1027 1033
19. N.K. Ibrahim, N. Desai, S. Legha, P. Soon-Shiong, R.L. Theriault, E. Rivera, B. Esmaeli, S.E. Ring, A. Bedikian, G.N. Hortobagyi, and J.A. Ellerhorst Phase I and pharmacokinetic study of ABI-007 a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel Clin. Cancer Res. 8 2002 1038 1044
20. T. Ishii, T. Asai, D. Oyama, Y. Agato, N. Yasuda, T. Fukuta, K. Shimizu, T. Minamino, and N. Oku Treatment of cerebral ischemia-reperfusion injury with PEGylated liposomes encapsulating FK506 FASEB J. 27 2013 1362 1370
21. A. Jithan, K. Madhavi, M. Madhavi, and K. Prabhakar Preparation and characterization of albumin nanoparticles encapsulating curcumin intended for the treatment of breast cancer Int. J. Pharm. Invest. 1 2011 119 125
22. W.A. Jurewicz Tacrolimus versus cyclosporin immunosuppression: long-term outcome in renal transplantation Nephrol. Dial. Transplant. 18 2003 i7 i11
23. D.N. Kapoor, F.V. Manvi, R.C. Doijad, and S. Dhawan Prednisolone-loaded albumin nanospheres: in vitro and in vivo evaluation studies PDA J. Pharm. Sci. Technol. 62 2008 111 124
24. F. Kratz Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles J. Control. Release 132 2008 171 183
25. F. Kratz WITHDRAWN: a clinical update of using albumin as a drug vehicle - a commentary J. Control. Release 190 2014 331 336
26. S.D. Li, and L. Huang Pharmacokinetics and biodistribution of nanoparticles Mol. Pharm. 5 2008 496 504
27. X. Li, P. Li, Y. Zhang, Y. Zhou, X. Chen, Y. Huang, and Y. Liu Novel mixed polymeric micelles for enhancing delivery of anticancer drug and overcoming multidrug resistance in tumor cell lines simultaneously Pharm. Res. 27 2010 1498 1511
28. Z. Liu, Y. Jiao, Y. Wang, C. Zhou, and Z. Zhang Polysaccharides-based nanoparticles as drug delivery systems Adv. Drug Deliv. Rev. 60 2008 1650 1662
29. R.M. Mainardes, and R.C. Evangelista PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution Int. J. Pharm. 290 2005 137 144
30. A. Moutabarrik, M. Ishibashi, H. Kameoka, A. Ogata, N. Kawaguchi, Y. Takano, Y. Kokado, S. Takahara, H. Jiang, and S. Onishi In vitro FK 506 kidney tubular cell toxicity Transplant. Proc. 23 1991 3137 3140
31. T. Nassar, A. Rom, A. Nyska, and S. Benita Novel double coated nanocapsules for intestinal delivery and enhanced oral bioavailability of tacrolimus, a P-gp substrate drug J. Control. Release 133 2009 77 84
32. S. Nicolai, and S. Bunyavanich Hypersensitivity reaction to intravenous but not oral tacrolimus Transplantation 94 2012 e61 63
33. X.L. Qin, H.C. Bi, C.X. Wang, J.L. Li, X.D. Wang, L.S. Liu, X. Chen, and M. Huang Study of the effect of Wuzhi tablet (Schisandra sphenanthera extract) on tacrolimus tissue distribution in rat by liquid chromatography tandem mass spectrometry method Biomed. Chromatogr. 24 2010 399 405
34. C. Roney, P. Kulkarni, V. Arora, P. Antich, F. Bonte, A. Wu, N.N. Mallikarjuana, S. Manohar, H.F. Liang, A.R. Kulkarni, H.W. Sung, M. Sairam, and T.M. Aminabhavi Targeted nanoparticles for drug delivery through the blood-brain barrier for Alzheimer's disease J. Control. Release 108 2005 193 214
35. V.A. Ruff, and K.L. Leach Direct demonstration of NFATp dephosphorylation and nuclear localization in activated HT-2 cells using a specific NFATp polyclonal antibody J. Biol. Chem. 270 1995 22602 22607
36. L.J. Scott, K. McKeage, S.J. Keam, and G.L. Plosker Tacrolimus: a further update of its use in the management of organ transplantation Drugs 63 2003 1247 1297
37. K.T. Shaw, A.M. Ho, A. Raghavan, J. Kim, J. Jain, J. Park, S. Sharma, A. Rao, and P.G. Hogan Immunosuppressive drugs prevent a rapid dephosphorylation of transcription factor NFAT1 in stimulated immune cells Proc. Natl. Acad. Sci. U. S. A. 92 1995 11205 11209
38. R. Venkataramanan, A. Jain, E. Cadoff, V. Warty, K. Iwasaki, K. Nagase, A. Krajack, O. Imventarza, S. Todo, and J.J. Fung Pharmacokinetics of FK 506: preclinical and clinical studies Transplant. Proc. 22 1990 52 56
39. M. von Suesskind-Schwendi, M. Gruber, D. Touraud, W. Kunz, C. Schmid, S.W. Hirt, and K. Lehle Pharmacokinetics of a self-microemulsifying drug delivery system of tacrolimus Biomed. Pharmacother. 67 2013 469 473
40. P.E. Wallemacq, and R. Reding FK506 (tacrolimus) a novel immunosuppressant in organ transplantation: clinical, biomedical, and analytical aspects Clin. Chem. 39 1993 2219 2228
41. Y. Wang, C. Wang, S. Fu, Q. Liu, D. Dou, H. Lv, M. Fan, G. Guo, F. Luo, and Z. Qian Preparation of tacrolimus loaded micelles based on poly(varepsilon-caprolactone)-poly(ethylene glycol)-poly(varepsilon-caprolactone) Int. J. Pharm. 407 2011 184 189
42. Y. Wei, L. Li, Y. Xi, S. Qian, Y. Gao, and J. Zhang Sustained release and enhanced bioavailability of injectable scutellarin-loaded bovine serum albumin nanoparticles Int. J. Pharm. 476 2014 142 148
43. R.H. Wiesner A long-term comparison of tacrolimus (FK506) versus cyclosporine in liver transplantation: a report of the United States FK506 Study Group Transplantation 66 1998 493 499
44. B. Wilson, T.V. Ambika, R.D. Patel, J.L. Jenita, and S.R. Priyadarshini Nanoparticles based on albumin: preparation, characterization and the use for 5-flurouracil delivery Int. J. Biol. Macromol. 51 2012 874 878
45. B. Wilson, Y. Lavanya, S.R. Priyadarshini, M. Ramasamy, and J.L. Jenita Albumin nanoparticles for the delivery of gabapentin: preparation, characterization and pharmacodynamic studies Int. J. Pharm. 473 2014 73 79
46. W. Xu, P. Ling, and T. Zhang Toward immunosuppressive effects on liver transplantation in rat model: tacrolimus loaded poly(ethylene glycol)-poly(d,l-lactide) nanoparticle with longer survival time Int. J. Pharm. 460 2014 173 180
47. K. Yokogawa, M. Takahashi, I. Tamai, H. Konishi, M. Nomura, S. Moritani, K. Miyamoto, and A. Tsuji P-glycoprotein-dependent disposition kinetics of tacrolimus: studies in mdr1a knockout mice Pharm. Res. 16 1999 1213 1218
48. H. Yura, N. Yoshimura, T. Hamashima, K. Akamatsu, M. Nishikawa, Y. Takakura, and M. Hashida Synthesis and pharmacokinetics of a novel macromolecular prodrug of tacrolimus (FK506), FK506-dextran conjugate J. Control. Release 57 1999 87 99
49. J.Y. Zhang, B. He, W. Qu, Z. Cui, Y.B. Wang, H. Zhang, J.C. Wang, and Q. Zhang Preparation of the albumin nanoparticle system loaded with both paclitaxel and sorafenib and its evaluation in vitro and in vivo J. Microencapsul. 28 2011 528 536